New heart pump could be safer for High-Risk patients

NCT ID NCT07010965

Ongoing Disease control Sponsor: magAssist, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares a new, smaller heart pump called NyokAssist to a standard balloon pump in people having high-risk heart procedures to open blocked arteries. The goal is to see if the new pump reduces serious heart and brain complications. About 236 adults will take part in this randomized trial.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIGH RISK PCI

Contacts and locations

Locations

Beijing Anzhen Hospital Capital Medical University

Beijing, China
Fuwai Yunnan Hospital Chinese Academy of Medical Science

Yunnan, China
Guangdong Provincial People's Hospital

Guangzhou, China
Nanfang Hospital Southern Medical University

Guangzhou, China
Peking University First Hospital Taiyuan Hospital

Taiyuan, China
The First Affiliated Hospital of Xi'an Jiaotong University

Xi'an, China
The First Hospital of Lanzhou University

Lanzhou, China
The Second Affiliated Hospital Zhejiang University School of Medicine

Hangzhou, China
The Second Affiliated Hospital of Harbin Medical University

Harbin, China
The Second Xiangya Hospital of Central South University

Changsha, China
Xiamen Cardiovascular Hospital Xiamen University

Xiamen, China
ZhongShan Hospital Fudan University

Shanghai, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.